The Toolkit will help raise awareness for the upcoming World TB Day and can be used, adapted, or tailored to fit everyone's needs and vision.

Have your voice heard - share your views and opinions on draft TB Key Asks to be included in the HLM Political Declaration; Deadline: 21 March 2023.

GENEVA/WASHINGTON, 09 March 2023 – The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the United States Agency for International Development (USAID) and the Stop TB Partnership announced a new collaboration today with Molbio Diagnostics that significantly reduces the price of the Truenat® MTB and MTB Plus tests, including a supply of MTB-RIF Dx tests for subsequent testing for rifampicin resistance, and ensures timely service and maintenance of diagnostic instruments. This collaboration will expand equitable access to quality rapid testing to underserved populations across all countries supported by the Global Fund, USAID and the Stop TB Partnership.

The UN General Assembly formally adopts the Modalities Resolution for the upcoming UN High-Level Meeting on TB, which sets out the dates, agenda, logistics, and other critical details for the meeting.

The Stop TB Partnership releases the toolkit for the World TB Day campaign Yes! We Can End TB.

The Stop TB Partnership released new guidance, Priority TB community, rights & gender interventions for inclusion in Global Fund applications 2023-2025, outlining six priority interventions for inclusion, and containing useful annexes on engaging in Global Fund Grant Cycle 7 processes.

Yes! We Can End TB.
The theme brings attention to TB and that it is in our collective power to end TB by 2030 and therefore reach the Sustainable Development Goals.

The Stop TB Partnership and partners will host a webinar on 26 January 2023, What's new in childhood TB.

GFAN is selected to coordinate the Affected Communities and Civil Society Platform for the 2023 UN High-Level Meeting on TB. Applications are now being accepted for lead consultant(s) to support this work (Deadline: 5 January 2023).

The manual provides an overview of the recommended use of IGRAs as a class of in-vitro tests for the detection of TB infection and describes their performance, steps for use and implementation considerations.